Cargando…

A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials

Sarecycline is a novel, narrow-spectrum, third generation tetracycline class antibiotic approved by the Food and Drug Administration (FDA) for the treatment of moderate-to-severe acne in patients ages nine and older. Recently, focus has increased on whether treatment responses differ in acne in skin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Angela Yen, Hurley, Kara, Moore, Stephen Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854598/ https://www.ncbi.nlm.nih.gov/pubmed/36671290 http://dx.doi.org/10.3390/antibiotics12010089

Ejemplares similares

Effect of Sarecycline on the Acne Symptom and Impact Scale and Concerns in Moderate-to-Severe Truncal Acne in Open-Label Pilot Study
por: Moore, Angela Yen, et al.
Publicado: (2023)

Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris
por: Moore, Angela Yen, et al.
Publicado: (2019)

Sarecycline: A Review of Preclinical and Clinical Evidence
por: Moore, Angela Yen, et al.
Publicado: (2020)

Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity
por: Grada, Ayman, et al.
Publicado: (2022)

Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy
por: Grada, Ayman, et al.
Publicado: (2021)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
por: Rahman, Farah, et al.
Publicado: (2022)

Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
por: Zhanel, George, et al.
Publicado: (2018)

Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2021)

Sarecycline: First Global Approval
por: Deeks, Emma D.
Publicado: (2019)

Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota
por: Moura, Ines B., et al.
Publicado: (2022)

Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism
por: Lomakin, Ivan B, et al.
Publicado: (2023)

Correction to: Sarecycline: First Global Approval
por: Deeks, Emma D.
Publicado: (2019)

Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Imai, Noboru, et al.
Publicado: (2023)

Seasonal Antimicrobial Activity of the Airway: Post-Hoc Analysis of a Randomized Placebo-Controlled Double-Blind Trial
por: Vargas Buonfiglio, Luis G., et al.
Publicado: (2020)

Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation
por: Bunick, Christopher G., et al.
Publicado: (2021)

935. Effect of Tesamorelin in People with HIV with and without Dorsocervical Fat: Post Hoc Analysis of Phase III Double Blind Placebo Control Trial
por: Rahman, Farah, et al.
Publicado: (2020)

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
por: Alev, Levent, et al.
Publicado: (2017)

Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement
por: Rinaldi, Fabio, et al.
Publicado: (2022)

Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials
por: Lodise, Thomas, et al.
Publicado: (2020)

Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials
por: Dombi, Z.B., et al.
Publicado: (2021)

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
por: Marrinan, Sarah L., et al.
Publicado: (2017)

Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
por: Renz, Susanne, et al.
Publicado: (2021)

A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes
por: McGee, Claire, et al.
Publicado: (2023)

Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome
por: Batool, Zahra, et al.
Publicado: (2020)

Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials
por: Kornstein, Susan, et al.
Publicado: (2018)

Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies
por: Enomoto, Hiroyuki, et al.
Publicado: (2017)

Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
por: Mease, Philip, et al.
Publicado: (2022)

Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study
por: Sauder, Colin, et al.
Publicado: (2022)

Treatment of Levodopainduced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
por: Habibi, Amir Hassan, et al.
Publicado: (2018)

Twelve‐week, multicenter, placebo‐controlled, randomized, double‐blind, parallel‐group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication
por: Kawashima, Makoto, et al.
Publicado: (2017)

Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials
por: Hasegawa, Kazuko, et al.
Publicado: (2021)

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies
por: Costamagna, Isabella, et al.
Publicado: (2021)

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
por: Zhang, Tingting, et al.
Publicado: (2022)

Painful enlarging umbilical nodule with cyclical swelling
por: Moore, Angela Yen, et al.
Publicado: (2022)

Painful medial thigh ulcer
por: Moore, Angela Yen, et al.
Publicado: (2022)

Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021)

Evaluation of levetiracetam as a pre-operative anxiolytic: A randomized, double-blind, placebo-controlled study
por: Choupoo, Nang Sujali, et al.
Publicado: (2015)

Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
por: Yoritaka, Asako, et al.
Publicado: (2021)

Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study
por: Harvey, Philip D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qkfflovpn919ika17hqk6vkn65